News24
A new report warns that SA’s rollout of the six-monthly HIV-prevention jab, lenacapavir, could falter after US funding cuts gutted outreach networks. Findings draw on interviews with healthcare workers and high-risk groups in Cape Town and Johannesburg.
Go to News Site